Stock listing

NASDAQ:OCRX Ocera Therapeutics Inc Stock

Follow Ocera Therapeutics Inc into a list and get an email when it puts out news.

Last close · NASDAQ:OCRX

$1.79 USD

Close on Dec 8, 2017 · No longer trades

Apr 4, 2011 to last close -96.3% · weekly closes, Apr 4, 2011 – Dec 8, 2017
Lowest – highest close
$0.55 – $62.88 USDSince Apr 4, 2011 · lowest Feb 7, 2017 · highest Feb 28, 2012

Delisted NASDAQ:OCRX no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:OCRX
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Ocera Therapeutics Inc on 6ix

Decks
5 decks · latest Mar 8, 2017

Decks

DeckKindSlidesDate
37th Annual Cowen Healthcare Conference 2017Conference31 slidesMar 8, 2017
Investor Presentation (January 2017)Investor deck25 slidesJan 9, 2017
Investor Presentation (March 2015)Investor deck29 slidesMar 2, 2015
Tranzyme — Merger or Acquisition (April 2013)Merger or acquisition28 slidesApr 24, 2013
Tranzyme — Investor Presentation (November 2012)Investor deck13 slidesNov 28, 2012

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Lars G. Ekman
Other companies: Prothena Corporation plc (Chair Emeritus · Since at least Dec 20, 2012); Ultragenyx Pharmaceutical Inc. (Director · Mar 17, 2016 – Jun 24, 2022 · Past); Spark Therapeutics Inc (Director · Jan 29, 2015 – Dec 17, 2019 · Past); Amarin Corporation plc (Director · Dec 30, 2010 – Jun 27, 2022 · Past); InterMune Inc (Director · May 10, 2010 – Sep 29, 2014 · Past); Aryx Therapeutics Inc (Director · Apr 30, 2010 – Apr 30, 2010 · Past)
Director · Jul 15, 2013 – Jun 11, 2014 · Past
Rajiv Patni
Other companies: Septerna, Inc. (Chief Medical Officer · Since at least Aug 24, 2026); BioXcel Therapeutics, Inc. (Director · Since at least Jan 15, 2025); Quince Therapeutics, Inc. (Director · Since at least Feb 15, 2024); Reata Pharmaceuticals Inc (EVP, Chief R&D Officer · Jun 12, 2023 – Sep 26, 2023 · Past); Portola Pharmaceuticals Inc (EVP, CMO · Feb 3, 2020 – Jul 2, 2020 · Past); Adamas Pharmaceuticals Inc (Chief Medical Officer · Jun 8, 2015 – Apr 8, 2019 · Past)
Chief Development Officer · Sep 2, 2014 – May 7, 2015 · Past
Steven P James
Other companies: Allakos Inc (Director · Jul 18, 2018 – May 15, 2025 · Past); Cascadian Therapeutics Inc (Director · Feb 26, 2015 – Mar 9, 2018 · Past)
Director · Sep 17, 2014 – Dec 11, 2017 · Past

Open People

Log in to ask 6ix AI your own questions about Ocera Therapeutics Inc.